Medtronic, Inc. (NYSE: MDT) today announced the appointment of D. Cameron Findlay as senior vice president, general counsel and corporate secretary effective Aug. 24, 2009. In this role, Findlay will report to Medtronic Chairman and CEO, Bill Hawkins.

As senior vice president, general counsel and corporate secretary, Findlay will oversee Medtronic’s legal function on a global basis. In addition, he will direct Medtronic’s government affairs department and serve as a member of Medtronic’s executive committee.

“I am pleased to name Cam Findlay to this important executive position at Medtronic, as he has an outstanding reputation for guidance, ethical leadership and integrity,” said Hawkins. “In addition to his role as general counsel, I also asked Cam to participate in the leadership of our initiative focused on the development of new standards for clarity and transparency in our relationship with physicians.”

Prior to joining Medtronic, Findlay served for six years as executive vice president and general counsel at Aon Corporation, the world’s largest insurance broker. From 2001 to 2003, he served as the deputy secretary at the U.S. Department of Labor, the second-ranking official in that cabinet department. Before that, he was a partner at the international law firm of Sidley Austin LLP where his practice included complex commercial, financial, securities, anti-trust and appellate litigation. Additional career experience included serving as deputy assistant to the President and counselor to the Chief of Staff at the White House in the administration of George H. W. Bush, and as a law clerk at the U.S. Supreme Court for Justice Antonin Scalia.

Findlay received his juris doctor degree from Harvard Law School in 1987 and a master’s degree in philosophy, politics and economics from Oxford University, where he was a Marshall Scholar. He earned a bachelor’s degree in political science from Northwestern University.

About Medtronic

Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health and extending life for millions of people around the world.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s Annual Report on Form 10-K for the year ended April 24, 2009. Actual results may differ materially from anticipated results.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6019494〈en

Medtronic, Inc.
Jeff Warren, 763-505-2696
Investor Relations
or
Chuck Grothaus, 763-505-2614
Public Relations